URINARY CALCIUM EXCRETION IN CHILDREN WITH FAMILIAL MEDITERRANEAN FEVER

Öz

Background and aim: Familial Mediterranean Fever (FMF) is a hereditary multi-systemic disease that is frequent in Turkey. Our aim is to determine the frequency of hypercalciuria and the risk of urinary stone disease in children with FMF. Materials and methods: In our study twenty-three children with acute phase FMF disease and 58 children with remission phase FMF disease were included. They are diagnosed by anamnesis, clinical and molecular genetic studies. 25 age- and gender-matched healthy control children were included. Acute phase reaction was defined by increased acute phase reactants (AFR) including erythrocyte sedimentation rate, C-reactive protein and fibrinogen levels. Results: Children with acute phase FMF had higher AFR levels when compared with both remission phase and the control subjects (P<0.001 for each). However, no difference was found in AFR levels between remission phase FMF and the control subjects (P>0.05). Urinary daily calcium excretion was higher during acute attack (4.63±1.75 mg/kg/day) than those of both remission phase (3.88±0.97 mg/kg/day) and the control group (3.30±0.82 mg/kg/day). However the difference reached to a significant level between acute attack phase and the control subjects (P=0.013). The frequency of hypercalciuria was 30% in acute phase, 26% in remission phase and 4.5% in control subjects.Conclusions: High urinary calcium excretion of FMF children should be taken into account considering elevated urinary calcium as a metabolic risk factor for urinary stone formation

Anahtar Kelimeler

• Children, FMF, urinary stone disease, hypercalciuria

Ailesel Akdeniz Ateşi Bulunan Çocuklarda İdrarla Kalsiyum Atılımı

Öz

Giriş ve amaç: Genetik geçişli multisistemik bir hastalık olan Ailevi Akdeniz Ateşi (Familial Mediterranean fever, FMF) Türkiye’de seyrek değildir. FMF hastalarında hiperkalsiüri sıklığını belirleyerek bu grup hastalarda böbrek taşı riskini değerlendirmeyi amaçladık.Gereç ve yöntemler: Klinik bulgular ve moleküler genetik çalışmalarla FMF tanısı konup mutasyonları belirlenen 23 atak dönemi FMF’li, 58 remisyonda FMF’li hasta ve 25 adet yaş, cins ve antropometrik ölçümler bakımından benzer sağlıklı kontrol grubu çalışmaya alındı. Öykü, klinik muayene ve akut faz reaktanları (kan sedimantasyon hızı, C-reaktif protein ve fibrinojen düzeyleri) ile atak dönemleri tespit edildi. Olgulara diyet kısıtlanması yapılmadan 24 saatlik idrar kalsiyum düzeyleri ölçüldü.Bulgular: Atak dönemi FMF’li çocuklarda akut faz reaktanları (AFR) düzeyleri, hem ataksız dönem (P<0.001) hem de kontrol grubundan (P<0.001) anlamlı yüksek bulunurken; ataksız dönem ile sağlıklı kontroller arasında AFR düzeyleri bakımından anlamlı fark saptanmadı (P>0.05). Atak dönemlerinde FMF’li hastaların idrar kalsiyum düzeyleri (4.63±1.75 mg/kg/gün), hem ataksız dönemden (3.88±0.97 mg/kg/gün) hem de kontrollerden (3.30±0.82 mg/kg/gün) daha yüksek bulundu. Ancak, sadece atak dönemi FMF’liler ile kontrol grubu arasındaki fark istatistiksel olarak anlamlı düzeye ulaştı (P=0.013). Hiperkalsiüri sıklığı atak sırasında %30, ataklar arasında %26 ve kontrol grubunda %4.5 olarak bulundu.Sonuçlar: Pediatrik FMF hastalarında idrarla kalsiyum atılım fazlalığı dikkate alınıp, kalsiyum fazlalığının metabolik olduğu düşünülerek böbrek taşı riskine karşı dikkatli olunması uygun olacaktır.

Anahtar Kelimeler

• Çocuk, FMF, üriner sistem taş hastalığı, hiperkalsiüri

Kaynakça

1. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet ; 351: 659-664. Özen S, Karaaslan Y, Özdemir O, Saatci U, Bakkaloglu A, Koroglu E, Tezcan S. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 1998; : 2445-2449.
2. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E; Turkish FMF Study Group. Familial Mediterranean Fever (FMF) in Turkey: Results of nationwide multicenter study. Medicine 2005; 84: 1-11.
3. Knecht A, de Beer FC, Pras M. Serum Amyloid A protein in fami- lial Mediterranean fever. Ann Intern Med 1985;102: 71-72.
4. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The Inter- national FMF Consortium. Cell 1997; 90: 797-807.
5. Caudarella R, Vescini F, Buffa A, La Manna G, Stefoni S. Osteo- porosis and Urolithiasis. Urol Int 2004; 72: 17–19.
6. Locker FG. Hormonal regulation of calcium homeostasis. Nurs Clin North Am 1996;31:797–803.
7. Noe H. Hypercalciuria and pediatric stone recurrences with and without structural abnormalities J Urology 2000; 164: 1094 1096.
8. Butani L, Kalia A. Idiopathic hypercalciuria in children, how valid is the existing diagnostic criteria? Pediatr Nephrol 2004; 19: 577

9. Bakkaloglu A. Familial Mediterranean fever. Pediatr Nephrol ;18:853-859. Tchernitchko D, Legendre M, Delahaye A, Cazeneuve C, Niel F, Goossens M, Amselem S, Girodon E. Clinical evaluation of a re- verse hybridization assay for the molecular detection of twelve MEFV gene mutations. Clin Chem 2003; 49: 1942-1945.
10. Orun E, Yalcınkaya F, Ozkaya N, Akar N, Gokce H. FMF hasta- lığında akut faz yanıtı ile TNF-α IL-8 ve IL-6 değerlendirilmesi. Ankara ÜniTıp Fak Mecm 2002;55: 123-128.
11. Bentancur AG, Naveh N, Lancri J, Selah BA, Shtrasburg S, Livneh A. Urine leukotriene B4 in familial Mediterranean fever and other forms of right lower abdominal pain. Acad Emerg Med. 2005;12: 674.
12. Erbagci A, Erbagci AB,Yilmaz M, Yagci F, Tarakcioglu M, Yurt- seven C, Koyluoglu O, Sarica K. Pediatric urolithiasis--evaluation of risk factors in 95 children. Scand J Urol Nephrol 2003; 37: 133.
13. Bercem G, Cevit O, Toksoy HB, Içagasioglu D, Gültekin A, Tan- zer F. Asymptomatic hypercalciuria: Prevalence and metabolic characteristics. Indian J Pediatr. 2001; 68: 315-318.
14. Gang N, Drenth JP, Langevitz P, Zemer D, Brezniak N, Pras M, van der Meer JW, Livneh A. Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 1999; 26: 890-897.
15. Samuels J, Aksentijevich I, Torosyan Y, Centola M ,Deng Z, Sood R, Kastner DL. Familial Mediterranean fever at the Millennium Clinical spectrum ancient mutations and a survey of 100 Ame- rican referrals to the National Institutes of Health.Medicine ;77:268-297. Gabay C, Kushner I. Acute-phase proteins and other systemic res- ponses to inflamation The New Eng J Med 1999;340:448-454.
16. Lin E, Calvono SE, Lowry SF. Inflammatory cytokines and cell response in surgery.Surgery 2000;127:117-126.
17. Ross R. Atherosclerosis, an inflammatory disease. N Eng J Med1999; 340: 115–126
18. Cham BE. Plaque cholesterol and calcium: the value of EBCT in the detection of coronary atherosclerosis. Eur J Clin Invest2001; : 467–468 .
19. Brancaccio D, Tetta C, Gallieni M, Panichi V. Inflammation, CRP, calcium overload and a high calcium–phosphate product: a ‘liai- son dangereuse’. Nephrol Dial Transplant 2002 ;17: 201-203
20. Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium- binding S100 proteins as clinical laboratory markers of inflamma- tion.Clin Chim Acta. 2004;344:37-51 .
21. Gomes B, Cabral MD, Gallard A, Savignac M, Paulet P, Druet P, Mariamé B, Moreau M, Leclerc C, Guéry JC, Pelletier L. Calcium channel blocker prevents T helper type 2 cell-mediated airway inf- lammation. Am J Respir Crit Care Med 2007;175:1117-1124.